β-defensin 29 Activators
β-Defensin 29, a vital component of the innate immune system, plays a crucial role in defending against microbial threats. As an antimicrobial peptide, it contributes to the first line of defense by disrupting microbial membranes and exerting bactericidal effects. Understanding the mechanisms governing β-defensin 29 activation provides insights into the intricate interplay between cellular pathways and immune responses.
Activation of β-defensin 29 involves a network of cellular signaling cascades influenced by various chemical activators. Compounds such as retinoic acid, thiazolidinediones, sulforaphane, butyrate, genistein, resveratrol, 5-azacytidine, alpha-lipoic acid, luteolin, diallyl disulfide, EGCG, and quercetin exert their effects through specific pathways, ranging from nuclear receptors to epigenetic modifications. These pathways converge at the DEFB29 promoter, leading to enhanced transcription and synthesis of β-defensin 29. The antimicrobial potential of β-defensin 29 is reinforced by these activators, providing a robust defense mechanism against a diverse array of pathogens. This multifaceted approach to activation underscores the adaptability and complexity of the innate immune system, offering avenues for further exploration in the development of strategies to bolster host defenses against microbial challenges.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Retinoic Acid, all trans | 302-79-4 | sc-200898 sc-200898A sc-200898B sc-200898C | 500 mg 5 g 10 g 100 g | $66.00 $325.00 $587.00 $1018.00 | 28 | |
Retinoic acid serves as a direct activator of β-defensin 29 by binding to retinoic acid receptors (RARs). This complex translocates to the DEFB29 promoter region, enhancing transcription. The resulting increase in β-defensin 29 expression contributes to innate immunity, providing antimicrobial defense against various pathogens. | ||||||
2,4-Thiazolidinedione | 2295-31-0 | sc-216281 | 50 g | $177.00 | 3 | |
Thiazolidinediones activate β-defensin 29 through PPARγ activation. Upon binding, PPARγ forms a complex with RXR, promoting binding to the PPRE in the DEFB29 promoter. This enhances transcription, leading to elevated β-defensin 29 expression and reinforcing the innate immune response against microbial challenges. | ||||||
D,L-Sulforaphane | 4478-93-7 | sc-207495A sc-207495B sc-207495C sc-207495 sc-207495E sc-207495D | 5 mg 10 mg 25 mg 1 g 10 g 250 mg | $153.00 $292.00 $489.00 $1325.00 $8465.00 $933.00 | 22 | |
Sulforaphane activates β-defensin 29 through the Keap1-Nrf2-ARE pathway. By promoting Nrf2 release from Keap1 inhibition, it facilitates Nrf2 translocation and binding to the DEFB29 promoter's ARE element. This up-regulation reinforces the antimicrobial function of β-defensin 29. | ||||||
Butyric acid | 107-92-6 | sc-214640 sc-214640A | 1 kg 10 kg | $64.00 $177.00 | ||
Butyrate activates β-defensin 29 by serving as a histone deacetylase inhibitor. By inhibiting histone deacetylation, it promotes an open chromatin structure in the DEFB29 promoter region, facilitating increased transcription. This epigenetic modulation results in elevated β-defensin 29 expression, contributing to innate immunity against microbial threats. | ||||||
Genistein | 446-72-0 | sc-3515 sc-3515A sc-3515B sc-3515C sc-3515D sc-3515E sc-3515F | 100 mg 500 mg 1 g 5 g 10 g 25 g 100 g | $45.00 $164.00 $200.00 $402.00 $575.00 $981.00 $2031.00 | 46 | |
Genistein indirectly activates β-defensin 29 by inhibiting the PI3K/Akt pathway. It hinders Akt phosphorylation, relieving its inhibition on FoxO3a. This allows FoxO3a to bind to the DEFB29 promoter, promoting transcription. This indirect activation leads to increased β-defensin 29 expression, bolstering the innate immune response. | ||||||
Resveratrol | 501-36-0 | sc-200808 sc-200808A sc-200808B | 100 mg 500 mg 5 g | $80.00 $220.00 $460.00 | 64 | |
Resveratrol activates β-defensin 29 indirectly by modulating the Nrf2/ARE pathway. Acting as an antioxidant, it enhances Nrf2 translocation, promoting its binding to the ARE element in the DEFB29 promoter. This up-regulation of β-defensin 29 contributes to antimicrobial defense. | ||||||
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
5-Azacytidine, a DNA methyltransferase inhibitor, directly activates β-defensin 29. By demethylating the DEFB29 promoter region, it alleviates epigenetic repression, allowing for enhanced transcription. This epigenetic modulation results in increased β-defensin 29 expression, contributing to innate immunity against microbial threats. | ||||||
α-Lipoic Acid | 1077-28-7 | sc-202032 sc-202032A sc-202032B sc-202032C sc-202032D | 5 g 10 g 250 g 500 g 1 kg | $69.00 $122.00 $212.00 $380.00 $716.00 | 3 | |
Alpha-lipoic acid activates β-defensin 29 through the Nrf2/ARE pathway. As an antioxidant, it promotes Nrf2 release from Keap1 inhibition, facilitating its translocation to the DEFB29 promoter's ARE element. This up-regulation strengthens the antimicrobial function of β-defensin 29. | ||||||
Luteolin | 491-70-3 | sc-203119 sc-203119A sc-203119B sc-203119C sc-203119D | 5 mg 50 mg 500 mg 5 g 500 g | $27.00 $51.00 $101.00 $153.00 $1925.00 | 40 | |
Luteolin activates β-defensin 29 by modulating the AP-1 pathway. It inhibits c-Fos and c-Jun activation, suppressing AP-1 transcriptional activity. As a consequence, the negative regulation on DEFB29 expression is alleviated, leading to increased β-defensin 29 synthesis with antimicrobial implications. | ||||||
Allyl disulfide | 2179-57-9 | sc-252359 | 25 g | $80.00 | ||
Allyl disulfide activates β-defensin 29 by influencing the MAPK pathway. It enhances ERK1/2 phosphorylation, positively regulating AP-1, which binds to the DEFB29 promoter. This leads to increased transcription of β-defensin 29, fortifying the antimicrobial defense mechanism. | ||||||